GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

China Animal Husbandry Industry Co 600195.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

6.24

-0.48%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥6.20bn

FY2016FY2025

Net income

CN¥171.3m

FY2016FY2025

Free cash flow

CN¥916.3m

FY2016FY2025

Shareholders' equity

CN¥5.67bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥6.20bnCN¥6.02bnCN¥5.41bnCN¥5.89bnCN¥5.30bnCN¥5.00bnCN¥4.14bnCN¥4.43bnCN¥4.07bnCN¥3.97bn
Gross profitCN¥1.09bnCN¥979.7mCN¥1.04bnCN¥1.23bnCN¥1.50bnCN¥1.28bnCN¥1.10bnCN¥1.28bnCN¥1.11bnCN¥1.15bn
Research and developmentCN¥152.8mCN¥203.9mCN¥122.8mCN¥143.3mCN¥162.6mCN¥169.9mCN¥169.6mCN¥166.6mCN¥115.5mCN¥231.8m
Operating incomeCN¥66.9mCN¥114.8mCN¥213.1mCN¥384.8mCN¥664.3mCN¥673.0mCN¥181.5mCN¥338.4mCN¥245.7mCN¥274.8m
Net incomeCN¥171.3mCN¥70.9mCN¥403.1mCN¥550.1mCN¥513.9mCN¥420.4mCN¥249.4mCN¥415.6mCN¥399.9mCN¥334.4m
Diluted earnings per share0.170.070.390.540.510.410.250.410.400.33

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥9.35bnCN¥8.84bnCN¥8.95bnCN¥7.94bnCN¥7.44bnCN¥6.77bnCN¥5.67bnCN¥6.83bnCN¥6.27bnCN¥6.03bn
Cash and short-term investments—CN¥1.09bnCN¥1.49bnCN¥875.2mCN¥1.23bnCN¥1.35bnCN¥741.3mCN¥840.8mCN¥495.5mCN¥1.07bn
Total liabilitiesCN¥2.79bnCN¥2.34bnCN¥2.41bnCN¥1.60bnCN¥1.56bnCN¥1.40bnCN¥1.07bnCN¥2.38bnCN¥2.35bnCN¥2.34bn
DebtCN¥299.6mCN¥1.01bnCN¥1.35bnCN¥322.9mCN¥199.0mCN¥156.3mCN¥90.0mCN¥1.28bnCN¥1.24bnCN¥1.27bn
Shareholders' equityCN¥5.67bnCN¥5.51bnCN¥5.52bnCN¥5.30bnCN¥4.91bnCN¥4.48bnCN¥4.10bnCN¥3.98bnCN¥3.66bnCN¥3.36bn
Shares outstanding1,021m1,021m1,021m1,021m1,016m1,016m1,010m1,010m1,010m1,010m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥1.16bnCN¥419.6mCN¥372.5m−CN¥222.1mCN¥383.0mCN¥666.1mCN¥27.1mCN¥186.4mCN¥202.5mCN¥633.4m
Capital spending−CN¥241.3m−CN¥458.8m−CN¥642.6m−CN¥464.1m−CN¥478.7m−CN¥532.0m−CN¥445.7m−CN¥217.5m−CN¥247.5m−CN¥200.0m
Free cash flowCN¥916.3m−CN¥39.2m−CN¥270.2m−CN¥686.2m−CN¥95.7mCN¥134.1m−CN¥418.6m−CN¥31.1m−CN¥45.0mCN¥433.4m
Dividends paid−CN¥49.3m−CN¥162.2m−CN¥209.5m−CN¥165.6m−CN¥127.0m−CN¥80.0m−CN¥145.6m−CN¥188.0m−CN¥148.9m−CN¥98.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥1.66bnCN¥1.51bnCN¥1.76bnCN¥1.65bnCN¥1.53bnCN¥1.26bnCN¥1.84bnCN¥1.70bn
Gross profitCN¥299.2mCN¥285.5mCN¥328.5mCN¥277.9mCN¥228.3mCN¥245.5mCN¥259.6mCN¥278.7m
Operating incomeCN¥88.0mCN¥92.7m−CN¥32.6mCN¥15.8mCN¥31.2mCN¥80.6m−CN¥16.2mCN¥35.2m
Net incomeCN¥25.7mCN¥24.2m−CN¥54.0mCN¥143.6mCN¥17.7mCN¥64.0m−CN¥10.9mCN¥19.0m
Diluted earnings per share0.030.02-0.050.140.020.06-0.010.02
Cash from operations———CN¥274.0mCN¥79.0m−CN¥311.0mCN¥731.0m−CN¥140.0m
Capital spending−CN¥29.0m−CN¥48.0m−CN¥84.0m−CN¥54.0m−CN¥53.0m−CN¥48.0m−CN¥113.0m−CN¥93.0m
Free cash flow———CN¥220.0mCN¥26.0m−CN¥359.0mCN¥618.0m−CN¥233.0m
Total assetsCN¥9.50bnCN¥9.72bnCN¥9.35bnCN¥9.32bnCN¥8.88bnCN¥8.95bnCN¥8.84bnCN¥8.99bn
Cash and short-term investments———CN¥1.36bnCN¥895.6mCN¥831.2mCN¥1.09bnCN¥622.0m
DebtCN¥266.7mCN¥349.5mCN¥299.6mCN¥900.5mCN¥1.11bnCN¥1.35bnCN¥1.00bnCN¥1.34bn
Shareholders' equityCN¥5.72bnCN¥5.69bnCN¥5.67bnCN¥5.72bnCN¥5.60bnCN¥5.57bnCN¥5.51bnCN¥5.49bn

Financial ratios

Data as of 9 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin17.5%16.3%19.2%21.0%28.4%25.6%
Operating margin4.0%0.8%3.9%6.5%9.5%7.0%
Net margin2.8%1.2%7.5%9.3%9.7%8.4%
Return on equity3.0%1.3%7.3%10.4%10.5%9.4%
Return on assets1.8%0.8%4.5%6.9%6.9%6.2%
Free cash flow yield20.4%12.8%14.8%3.5%12.6%17.5%
Revenue growth3.1%11.3%-8.2%11.1%6.1%20.9%
Earnings growth141.7%-82.4%-26.7%7.0%22.2%68.6%
Current ratio1.76x2.16x2.66x2.30x2.10x2.30x
Debt to equity0.05x0.18x0.25x0.06x0.04x0.03x
Equity ratio60.7%62.2%61.7%66.7%66.1%66.3%
Interest coverage8.50x1.14x8.11x27.36x46.47x39.71x
R&D as a share of sales2.5%3.4%2.3%2.4%3.1%3.4%
Buybacks as a share of market value0.0%0.0%0.0%-0.5%-0.0%-0.6%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1.7%4.4%3.9%
Operating income-44.2%-37.0%-14.6%
Net income-32.2%-16.4%-4.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin16.9%18.4%21.1%23.5%
Operating margin1.5%3.3%6.3%6.4%
Net margin2.0%5.1%6.3%7.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings46.996.730.121.625.830.939.015.421.227.4
Price to sales1.31.12.22.02.52.62.41.42.12.3

Dividends and splits

Per share, in the currency the company pays

Paid for 25 years. Last went ex-dividend on 7 Jul 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.0510.0230.1190.180.1510.1250.0790.144
  • 1.199-for-1 split · 8 Jul 2020
  • 7-for-5 split · 16 Jul 2019
  • 7-for-5 split · 10 Jul 2018
  • 1-to-1 reverse split · 28 Mar 2006
  • 3-for-2 split · 22 Sept 1999

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.